Navigation Links
FDA's Rick Friedman and Rebecca Rodriguez Confirmed as Closing Plenary Speakers for PDA Human Factors Workshop
Date:2/26/2013

BETHESDA, Md., Feb. 26 2013 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) announced today that Richard Friedman , Associate Director OMPQ, U.S. FDA, and Rebecca Rodriguez , Consumer Safety Officer, U.S. FDA, have been confirmed to deliver the closing plenary talks at the 2013 Human Factors and Human Error Reduction Workshop. The workshop will take place on April 17 – 18, 2013 at the Peabody Hotel in Orlando, Fla.

(Logo: http://photos.prnewswire.com/prnh/20130226/DC66667LOGO)  

"PDA continues Connecting People, Science and Regulation® by offering high-quality, technical workshops with the cooperation of officials from the FDA and other regulatory bodies worldwide," said Richard Johnson , PDA President and CEO. "In 2013, we are hosting seven conferences and workshops with the FDA on topics critical to pharmaceutical manufacturers, like glass packaging, supply chain and internal investigations. The 22nd annual PDA/FDA Joint Regulatory Conference stands out as the longest running, co-hosted meeting with FDA on GMP and other QA/QC and manufacturing topics. In addition, FDA officials like Mr. Friedman and Ms. Rodriguez continue to participate in our other meetings, like the Human Factors Workshop and the Annual Meeting."

The workshop will introduce the audience to the science of human factors and will illustrate the significant role and impact human factors has made in other industries ranging from aviation to nuclear control rooms. Following this brief introduction, the audience will participate in interactive sessions to learn how to use various human factors tools to help assess, understand and utilize the information needed to address manufacturing performance and/or safety concerns in processing and manufacturing facilities. 

Friedman and Rodriguez serve as the closing bookend to an event that begins with Keynote Speaker Dr. Najmedin Meshkati , Prof. of Civil/Environmental Engineering and Industrial Systems Engineering at the Viterbi School of Engineering, University of Southern California. In between, sessions featuring case studies will be shared by the moderators to highlight potential areas of concern, and how these areas have been improved through the use of human factors tools and techniques, resulting in improvements of operations, layout, workflow and overall system design. Speakers from Amgen, Radius Product Development and Abbott Medical Optics are already confirmed.

More information on the workshop is available at http://www.pda.org/humanfactors2013.

About PDA:
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide.

Media Inquiries: Walt Morris , 301-656-5900; morris@pda.org


'/>"/>
SOURCE Parenteral Drug Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gliknik Adds Incyte President & CEO Paul A. Friedman to its Board of Directors
2. RxAlly Adds Accomplished Clinical Services Expert And Pharmacist, Rebecca Chater, To The Companys Leadership Team
3. BD Board of Directors Elects Rebecca W. Rimel
4. High-Flo™ Confirmed As "Safety Sets"
5. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
6. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
7. Echo Therapeutics Announces Closing of Public Offering of Common Stock
8. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
9. Pharmaceuticals Announces $1.5 Million Second Closing in Private Placement
10. Winner Medical Announces Closing of Going Private Transaction
11. Trovagene Announces Closing of Private Placement of $3.76 Million from the Sale of Restricted Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):